These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16486034)

  • 21. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
    Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
    Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of antibodies in controlling dengue virus infection.
    van der Schaar HM; Wilschut JC; Smit JM
    Immunobiology; 2009; 214(7):613-29. PubMed ID: 19261353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent enhancement of virus infection and disease.
    Tirado SM; Yoon KJ
    Viral Immunol; 2003; 16(1):69-86. PubMed ID: 12725690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of an asymmetric two-strain dengue model.
    Kooi BW; Aguiar M; Stollenwerk N
    Math Biosci; 2014 Feb; 248():128-39. PubMed ID: 24434818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG; Alvarez M; Halstead SB
    Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children.
    Vazquez S; Lozano C; Perez AB; Castellanos Y; Ruiz D; Calzada N; Guzmán MG
    J Med Virol; 2014 Sep; 86(9):1576-83. PubMed ID: 24615872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A strong interferon response correlates with a milder dengue clinical condition.
    De La Cruz Hernández SI; Puerta-Guardo H; Flores-Aguilar H; González-Mateos S; López-Martinez I; Ortiz-Navarrete V; Ludert JE; Del Angel RM
    J Clin Virol; 2014 Jul; 60(3):196-9. PubMed ID: 24793964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.
    Nisalak A; Endy TP; Nimmannitya S; Kalayanarooj S; Thisayakorn U; Scott RM; Burke DS; Hoke CH; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Feb; 68(2):191-202. PubMed ID: 12641411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-efficiency analysis of voluntary vaccination against n-serovar diseases using antibody-dependent enhancement: A game approach.
    Kabir KMA; Tanimoto J
    J Theor Biol; 2020 Oct; 503():110379. PubMed ID: 32622789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays.
    Li XQ; Chen J; Huang YF; Ding XX; Liu LD; Qiu LW; Pan YX; Deng YQ; Hu DM; Di B; Qin CF; Che XY
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6503-11. PubMed ID: 23760532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.
    Paradkar PN; Ooi EE; Hanson BJ; Gubler DJ; Vasudevan SG
    Biosci Rep; 2011 Jun; 31(3):221-30. PubMed ID: 20858223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
    J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells.
    Konishi E; Tabuchi Y; Yamanaka A
    J Virol Methods; 2010 Feb; 163(2):360-7. PubMed ID: 19883692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling within-host signatures of dengue infection at the population level.
    Nikin-Beers R; Blackwood JC; Childs LM; Ciupe SM
    J Theor Biol; 2018 Jun; 446():79-86. PubMed ID: 29522728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
    Mady BJ; Kurane I; Erbe DV; Fanger MW; Ennis FA
    J Gen Virol; 1993 May; 74 ( Pt 5)():839-44. PubMed ID: 8492089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.
    Setthapramote C; Sasaki T; Puiprom O; Limkittikul K; Pitaksajjakul P; Pipattanaboon C; Sasayama M; Leuangwutiwong P; Phumratanaprapin W; Chamnachanan S; Kusolsuk T; Jittmittraphap A; Asai A; Arias JF; Hirai I; Kuhara M; Okuno Y; Kurosu T; Ramasoota P; Ikuta K
    Biochem Biophys Res Commun; 2012 Jul; 423(4):867-72. PubMed ID: 22713454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of monoclonal antibodies-escape variant of dengue virus serotype 1.
    Chua SK; Selvanesan S; Sivalingam B; Chem YK; Norizah I; Zuridah H; Kumarasamy V; Chua KB
    Singapore Med J; 2006 Nov; 47(11):940-6. PubMed ID: 17075660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever.
    Hu K; Thoens C; Bianco S; Edlund S; Davis M; Douglas J; Kaufman JH
    J Theor Biol; 2013 Feb; 319():62-74. PubMed ID: 23206388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of tertiary and quaternary infections on the epidemiology of dengue.
    Wikramaratna PS; Simmons CP; Gupta S; Recker M
    PLoS One; 2010 Aug; 5(8):e12347. PubMed ID: 20808806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.